![Kabir Kumar Nath](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kabir Kumar Nath
Directeur Général chez
COMPASS PATHWAYS PLC
Fortune : 759 961 $ au 31/05/2026
Profil
Kabir Kumar Nath is Chief Executive Officer & Director at Compass Pathways Plc since 2022.
Mr. Nath is Director at Otsuka Canada Pharmaceutical, Inc. since 2018.
Former roles include President & Chief Executive Officer at Otsuka America Pharmaceutical, Inc., Director & Head-North America Pharmaceutical at Otsuka Pharmaceutical Co., Ltd., Director at ZymoGenetics, Inc., Director at Inhibitex LLC, and President Commissioner at PT Taisho Pharmaceutical Indonesia.
Education includes an MBA from INSEAD and graduation from King's College, Cambridge.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
COMPASS PATHWAYS PLC 0,06 % | 06/04/2026 | 58 190 ( 0,06 % ) | 759 961 $ | 31/05/2026 |
Postes actifs de Kabir Kumar Nath
| Sociétés | Poste | Début |
|---|---|---|
| COMPASS PATHWAYS PLC | Directeur Général | 01/08/2022 |
Otsuka Canada Pharmaceutical, Inc.
 Otsuka Canada Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Directeur/Membre du Conseil | 23/03/2018 |
Anciens postes connus de Kabir Kumar Nath
| Sociétés | Poste | Fin |
|---|---|---|
| TAISHO PHARMACEUTICAL INDONESIA TBK PT | Président | - |
Otsuka America Pharmaceutical, Inc.
 Otsuka America Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceutical products | Directeur Général | - |
ZymoGenetics, Inc.
 ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology Develops protein based drugs | Directeur/Membre du Conseil | - |
Inhibitex LLC
 Inhibitex LLC Pharmaceuticals: MajorHealth Technology Develops drugs | Directeur/Membre du Conseil | - |
Otsuka Pharmaceutical Co., Ltd.
 Otsuka Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals and nutraceuticals | Directeur/Membre du Conseil | - |
Formation de Kabir Kumar Nath
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
4
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Otsuka Pharmaceutical Co., Ltd.
Otsuka Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals and nutraceuticals | Health Technology |
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology Develops protein based drugs | Health Technology |
Inhibitex LLC
Inhibitex LLC Pharmaceuticals: MajorHealth Technology Develops drugs | Health Technology |
INSEAD
 INSEAD Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Otsuka America Pharmaceutical, Inc.
Otsuka America Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceutical products | Health Technology |
PT Taisho Pharmaceutical Indonesia
 PT Taisho Pharmaceutical Indonesia Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceuticals | Health Technology |
King's College, Cambridge
 King's College, Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Otsuka Canada Pharmaceutical, Inc.
Otsuka Canada Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Compass Pathways Plc
 Compass Pathways Plc BiotechnologyHealth Technology Develops therapies and drugs for the treatment of mental health and neurocognitive conditions | Health Technology |
